Haber BA - Search Results

1

Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis.

Strizki JM, Diamond TL, Teal VL, Gilbert CL, Wang W, Stauffer N, Haber BA. Strizki JM, et al. Among authors: haber ba. J Infect Dis. 2024 Dec 16;230(6):e1287-e1298. doi: 10.1093/infdis/jiae287. J Infect Dis. 2024. PMID: 38853607 Free PMC article. Clinical Trial.

2

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.

Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, Stauffer N, Murata Y, Strizki JM, Teal VL, Gilbert CL, Haber BA. Limaye AP, et al. Among authors: haber ba. JAMA. 2023 Jul 3;330(1):33-42. doi: 10.1001/jama.2023.9106. JAMA. 2023. PMID: 37279999 Free PMC article.

3

Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study.

Gonzalez-Peralta RP, Wirth S, Squires RH, Mutschler F, Lang T, Pawlowska M, Sluzewski W, Majda-Stanislawska E, Fischler B, Balistreri WF, Jonas MM, Blondet N, Rosenthal P, Alkhouri N, Romero R, Grandhi A, Castronuovo P, Caro L, Du L, Rosenbloom DIS, Haber BA. Gonzalez-Peralta RP, et al. Among authors: haber ba. Hepatol Commun. 2023 Feb 14;7(3):e0031. doi: 10.1097/HC9.0000000000000031. eCollection 2023 Mar 1. Hepatol Commun. 2023. PMID: 36790337 Free PMC article.

4

Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance.

Hill DD, Kramer JR, Chaffin KR, Mast TC, Robertson MN, Kanwal F, Haber BA. Hill DD, et al. Among authors: haber ba. Ann Hepatol. 2023 Mar-Apr;28(2):100899. doi: 10.1016/j.aohep.2023.100899. Epub 2023 Jan 8. Ann Hepatol. 2023. PMID: 36632975 Free article.

5

Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.

Grebely J, Dore GJ, Altice FL, Conway B, Litwin AH, Norton BL, Dalgard O, Gane EJ, Shibolet O, Nahass R, Luetkemeyer AF, Peng CY, Iser D, Gendrano IN, Kelly MM, Hwang P, Asante-Appiah E, Haber BA, Barr E, Robertson MN, Platt H. Grebely J, et al. Among authors: haber ba. Ann Intern Med. 2022 Sep;175(9):1221-1229. doi: 10.7326/M21-4119. Epub 2022 Aug 9. Ann Intern Med. 2022. PMID: 35939812 Clinical Trial.

6

Dalgard O, Litwin AH, Shibolet O, Grebely J, Nahass R, Altice FL, Conway B, Gane EJ, Luetkemeyer AF, Peng CY, Iser D, Gendrano IN, Kelly MM, Haber BA, Platt H, Puenpatom A; CO-STAR Investigators. Dalgard O, et al. Among authors: haber ba. J Addict Dis. 2023 Jul-Sep;41(3):213-224. doi: 10.1080/10550887.2022.2088978. Epub 2022 Aug 3. J Addict Dis. 2023. PMID: 35920743 Free article. Clinical Trial.

7

Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials.

Nangia G, Vierling JM, Kwo P, Brown DD, Klopfer SO, Robertson MN, Haber BA, Reddy KR. Nangia G, et al. Among authors: haber ba. J Viral Hepat. 2020 Nov;27(11):1222-1233. doi: 10.1111/jvh.13357. Epub 2020 Aug 10. J Viral Hepat. 2020. PMID: 32594612

8

Efficacy and safety of elbasvir/grazoprevir for 12 weeks in people with hepatitis C virus infection aged 35 years or younger compared with older people: a retrospective integrated analysis.

Asselah T, Zeuzem S, Reau N, Hwang P, Long J, Talwani R, Robertson MN, Haber BA. Asselah T, et al. Among authors: haber ba. Curr Med Res Opin. 2020 Aug;36(8):1325-1332. doi: 10.1080/03007995.2020.1775075. Epub 2020 Jun 24. Curr Med Res Opin. 2020. PMID: 32459122

9

Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial.

Zhdanov K, Isakov V, Burnevich E, Kizhlo S, Bakulin I, Pokrovsky V, Liang L, Hwang P, Talwani R, Haber BA, Robertson MN. Zhdanov K, et al. Among authors: haber ba. Hepat Med. 2020 Apr 21;12:61-68. doi: 10.2147/HMER.S241418. eCollection 2020. Hepat Med. 2020. PMID: 32368162 Free PMC article.

10

Elbasvir/grazoprevir in women with hepatitis C virus infection taking oral contraceptives or hormone replacement therapy.

Hézode C, Kwo P, Sperl J, Hwang P, Long J, Talwani R, Robertson MN, Haber BA. Hézode C, et al. Among authors: haber ba. Int J Womens Health. 2019 Nov 20;11:617-628. doi: 10.2147/IJWH.S203022. eCollection 2019. Int J Womens Health. 2019. PMID: 31819666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters